MYMD

MyMD Pharmaceuticals, Inc.

3.53 USD
+0.21 (+6.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

MyMD Pharmaceuticals, Inc. stock is down -35.23% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.15% of the previous 15 February’s closed higher than January.

About MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc. focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy.